Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06545539 · ClinicalTrials.gov registry record · NA

Does Participation in a Fall Preparedness Program Improve Fall Efficacy Among Older Adults

A NA study, sponsored by Youngstown State University.

Not yet
Registry status
NA
Development phase
30
Enrollment target

NCT06545539: Clinical Trial NA study, sponsored by Youngstown State University.

NCT06545539 is a NA study that has not yet begun recruiting, run by Youngstown State University. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06545539, a NA study, has not yet begun recruiting, sponsored by Youngstown State University.

NOT YET RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

The purpose of this study is to determine if a fall preparedness program can reduce the fear of falling in older adults and subsequently improve their function and reduce falls with injury. Participants will perform baseline measures 4 weeks before intervention and again at the start of intervention. They will perform a 12-week intervention and then complete outcome measures again at the conclusion of the program.

Primary Outcome

Measure of self reported fall efficacy

Interventions

  • OTHER Fall Preparedness Exercise Class

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-08-01
Est. Completion 2026-12-31
Phase NA
Youngstown State University

19 total trials

What is known before NCT06545539 opens enrollment

NCT06545539 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Fall Preparedness Exercise Class is the first listed.

NCT06545539 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06545539 about?

NCT06545539 is a clinical study titled "Does Participation in a Fall Preparedness Program Improve Fall Efficacy Among Older Adults". The purpose of this study is to determine if a fall preparedness program can reduce the fear of falling in older adults and subsequently improve their function and reduce falls with injury. Participants will perform baseline measures 4 weeks before intervention and again at the start of interventio...

What is the current status of trial NCT06545539?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-08-01. Estimated completion is 2026-12-31.

What interventions are being tested in trial NCT06545539?

The interventions under investigation include: Fall Preparedness Exercise Class (OTHER).

Who is sponsoring clinical trial NCT06545539?

This trial is sponsored by Youngstown State University, which has 19 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06545539's enrollment target sits among peer trials

30 1593rd of 2000 higher than 299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06545539, the US trial registry maintained by the National Library of Medicine. NCT06545539 (small enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.